Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 21

Trial Status

Completed2

Role Distribution

Principal Investigator2
PI Rate100%

Activity Timeline

Clinical Trials (2)

NCT01665677Phase 2Completed
Atorvastatin as GVHD Prophylaxis for Allogeneic Hematopoietic Cell Transplantation
Graft vs Host Disease
PrincipalinvestigatorStart date: 2014-01-20
NCT01768845Not ApplicableCompleted
Unrelated Umbilical Cord Blood (UBC)Transplantation
Acute Lymphocytic Leukemia (ALL)Acute Myelogenous Leukemia (AML)Chronic Lymphocytic Leukemia (CLL)+6 more
PrincipalinvestigatorStart date: 2009-02-03

Research Network

Collaboration Network

5 collaborators·4 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Mary Horowitz, MD

Center for International Blood and Marrow Transplant Research

Related
24 trials

Shared therapeutic areas:

Multiple MyelomaLeukemia, Myelogenous, Chronic, BCR-ABL PositiveGraft vs Host Disease+6 more
Similarity Score27%

Yves Beguin, MD, PhD

CHU-ULg

Related
7 trials

Shared therapeutic areas:

Graft vs Host DiseaseHodgkin DiseasePrecursor Cell Lymphoblastic Leukemia-Lymphoma+6 more
Similarity Score27%

Arnon Nagler, MD

Chaim Sheba Medical Center

Related
12 trials

Shared therapeutic areas:

Hodgkin DiseaseMultiple MyelomaLymphoma, Non-Hodgkin+5 more
Similarity Score24%

David Avigan, MD

Beth Israel Deaconess Medical Center

Related
17 trials

Shared therapeutic areas:

Multiple MyelomaLeukemia, Myeloid, AcuteHodgkin Disease+3 more
Similarity Score18%

Helen Heslop, MD

Baylor College of Medicine

Related
17 trials

Shared therapeutic areas:

Lymphoma, Non-HodgkinPrecursor Cell Lymphoblastic Leukemia-LymphomaLeukemia, Lymphocytic, Chronic, B-Cell+2 more
Similarity Score15%

Mehdi Hamadani, MD

Medical College of Wisconsin

Related
5 trials

Shared therapeutic areas:

Graft vs Host Disease

Worked with same sponsors:

Mehdi HamadaniWest Virginia University
Collaborated on 1 trial
Similarity Score14%

Areej El-Jawahri, MD

Massachusetts General Hospital

Related
21 trials

Shared therapeutic areas:

Leukemia, Myeloid, AcuteGraft vs Host DiseaseMultiple Myeloma+1 more
Similarity Score12%

Jorge Cortes, MD

M.D. Anderson Cancer Center

Related
24 trials

Shared therapeutic areas:

Leukemia, Myeloid, AcuteLeukemia, Myelogenous, Chronic, BCR-ABL PositiveMyelodysplastic Syndromes+1 more
Similarity Score12%

Qifa Liu

Nanfang Hospital, Southern Medical University

Related
33 trials

Shared therapeutic areas:

Leukemia, Myeloid, AcuteMyelodysplastic SyndromesPrecursor Cell Lymphoblastic Leukemia-Lymphoma+1 more
Similarity Score12%

Jae Park, MD

Memorial Sloan Kettering Cancer Center

Related
17 trials

Shared therapeutic areas:

Precursor Cell Lymphoblastic Leukemia-LymphomaLeukemia, Lymphocytic, Chronic, B-CellLeukemia, Myeloid, Acute
Similarity Score9%

Publications (0)

No publications found for this investigator.

Clinical Trials (2)

Showing 2 of 2 trials

NCT01665677Phase 2PrincipalInvestigator

Atorvastatin as GVHD Prophylaxis for Allogeneic Hematopoietic Cell Transplantation

Graft vs Host Disease
Completed
NCT01768845Not ApplicablePrincipalInvestigator

Unrelated Umbilical Cord Blood (UBC)Transplantation

Acute Lymphocytic Leukemia (ALL)Acute Myelogenous Leukemia (AML)Chronic Lymphocytic Leukemia (CLL)+6 more
Completed

All 2 trials loaded